Convatec revenue rises in Q1 on 'strong' growth in advanced wound care, infusion care | 29 April 2021
29 April 2021 | 07:47am StockMarketWire.com - medical technology company Convatec reported an 8.7% rise in revenue in the first quarter, led by 'strong' growth in its advanced wound care and infusion care business. For the three months ended March 2021, revenue rose 8.7% to $500 million year-on-year. Advanced Wound Care revenue was up 8.8% on a reported basis, while Ostomy Care, its second largest business was up 6.7%. Infusion Care revenue increased 13.9%, and continence & critical care revenue was up 7.4%. Looking ahead, the company maintained its full year outlook, citing ongoing macro ...